2-[4-acetyl-5-(4-phenoxybutyl)-1,3-thiazol-2-yl]-N-(1,3-benzothiazol-2-yl)-3,4-dihydro-1H-isoquinoline-8-carboxamide;2-[4-acetyl-5-[3-(4-pyridin-3-ylphenoxy)propyl]-1,3-thiazol-2-yl]-N-(1,3-benzothiazol-2-yl)-3,4-dihydro-1H-isoquinoline-8-carboxamide;2-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]-5-[4-(4-pyrazolo[5,4-b]pyridin-1-ylphenoxy)butyl]-1,3-thiazole-4-carboxylic acid

C105H92N16O10S6 — CID 159929986

IUPAC2-[4-acetyl-5-(4-phenoxybutyl)-1,3-thiazol-2-yl]-N-(1,3-benzothiazol-2-yl)-3,4-dihydro-1H-isoquinoline-8-carboxamide;2-[4-acetyl-5-[3-(4-pyridin-3-ylphenoxy)propyl]-1,3-thiazol-2-yl]-N-(1,3-benzothiazol-2-yl)-3,4-dihydro-1H-isoquinoline-8-carboxamide;2-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]-5-[4-(4-pyrazolo[5,4-b]pyridin-1-ylphenoxy)butyl]-1,3-thiazole-4-carboxylic acid
SMILESCC(=O)c1nc(N2CCc3cccc(C(=O)Nc4nc5ccccc5s4)c3C2)sc1CCCCOc1ccccc1.CC(=O)c1nc(N2CCc3cccc(C(=O)Nc4nc5ccccc5s4)c3C2)sc1CCCOc1ccc(-c2cccnc2)cc1.O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1nc(C(=O)O)c(CCCCOc3ccc(-n4ncc5cccnc54)cc3)s1)CC2
InChIInChI=1S/C37H31N7O4S2.C36H31N5O3S2.C32H30N4O3S2/c45-34(42-36-40-29-10-1-2-11-30(29)49-36)27-9-5-7-23-17-19-43(22-28(23)27)37-41-32(35(46)47)31(50-37)12-3-4-20-48-26-15-13-25(14-16-26)44-33-24(21-39-44)8-6-18-38-33;1-23(42)33-32(12-6-20-44-27-15-13-24(14-16-27)26-8-5-18-37-21-26)46-36(39-33)41-19-17-25-7-4-9-28(29(25)22-41)34(43)40-35-38-30-10-2-3-11-31(30)45-35;1-21(37)29-28(16-7-8-19-39-23-11-3-2-4-12-23)41-32(34-29)36-18-17-22-10-9-13-24(25(22)20-36)30(38)35-31-33-26-14-5-6-15-27(26)40-31/h1-2,5-11,13-16,18,21H,3-4,12,17,19-20,22H2,(H,46,47)(H,40,42,45);2-5,7-11,13-16,18,21H,6,12,17,19-20,22H2,1H3,(H,38,40,43);2-6,9-15H,7-8,16-20H2,1H3,(H,33,35,38)
InChIKeyNZNATYYBYRXCAR-UHFFFAOYSA-N
MW1930.39 g/mol
LogP22.42
Rot. Bonds31

About 2-[4-acetyl-5-(4-phenoxybutyl)-1,3-thiazol-2-yl]-N-(1,3-benzothiazol-2-yl)-3,4-dihydro-1H-isoquinoline-8-carboxamide;2-[4-acetyl-5-[3-(4-pyridin-3-ylphenoxy)propyl]-1,3-thiazol-2-yl]-N-(1,3-benzothiazol-2-yl)-3,4-dihydro-1H-isoquinoline-8-carboxamide;2-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]-5-[4-(4-pyrazolo[5,4-b]pyridin-1-ylphenoxy)butyl]-1,3-thiazole-4-carboxylic acid

2-[4-acetyl-5-(4-phenoxybutyl)-1,3-thiazol-2-yl]-N-(1,3-benzothiazol-2-yl)-3,4-dihydro-1H-isoquinoline-8-carboxamide;2-[4-acetyl-5-[3-(4-pyridin-3-ylphenoxy)propyl]-1,3-thiazol-2-yl]-N-(1,3-benzothiazol-2-yl)-3,4-dihydro-1H-isoquinoline-8-carboxamide;2-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]-5-[4-(4-pyrazolo[5,4-b]pyridin-1-ylphenoxy)butyl]-1,3-thiazole-4-carboxylic acid (PubChem CID 159929986) has the molecular formula C105H92N16O10S6 and a molecular weight of 1930.39 g/mol. Its IUPAC name is 2-[4-acetyl-5-(4-phenoxybutyl)-1,3-thiazol-2-yl]-N-(1,3-benzothiazol-2-yl)-3,4-dihydro-1H-isoquinoline-8-carboxamide;2-[4-acetyl-5-[3-(4-pyridin-3-ylphenoxy)propyl]-1,3-thiazol-2-yl]-N-(1,3-benzothiazol-2-yl)-3,4-dihydro-1H-isoquinoline-8-carboxamide;2-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]-5-[4-(4-pyrazolo[5,4-b]pyridin-1-ylphenoxy)butyl]-1,3-thiazole-4-carboxylic acid.

Molecular Properties

Compound Name2-[4-acetyl-5-(4-phenoxybutyl)-1,3-thiazol-2-yl]-N-(1,3-benzothiazol-2-yl)-3,4-dihydro-1H-isoquinoline-8-carboxamide;2-[4-acetyl-5-[3-(4-pyridin-3-ylphenoxy)propyl]-1,3-thiazol-2-yl]-N-(1,3-benzothiazol-2-yl)-3,4-dihydro-1H-isoquinoline-8-carboxamide;2-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]-5-[4-(4-pyrazolo[5,4-b]pyridin-1-ylphenoxy)butyl]-1,3-thiazole-4-carboxylic acid
PubChem CID159929986
Molecular FormulaC105H92N16O10S6
Molecular Weight1930.39 g/mol
Exact Mass1928.55
IUPAC Name2-[4-acetyl-5-(4-phenoxybutyl)-1,3-thiazol-2-yl]-N-(1,3-benzothiazol-2-yl)-3,4-dihydro-1H-isoquinoline-8-carboxamide;2-[4-acetyl-5-[3-(4-pyridin-3-ylphenoxy)propyl]-1,3-thiazol-2-yl]-N-(1,3-benzothiazol-2-yl)-3,4-dihydro-1H-isoquinoline-8-carboxamide;2-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]-5-[4-(4-pyrazolo[5,4-b]pyridin-1-ylphenoxy)butyl]-1,3-thiazole-4-carboxylic acid
SMILESCC(=O)c1nc(N2CCc3cccc(C(=O)Nc4nc5ccccc5s4)c3C2)sc1CCCCOc1ccccc1.CC(=O)c1nc(N2CCc3cccc(C(=O)Nc4nc5ccccc5s4)c3C2)sc1CCCOc1ccc(-c2cccnc2)cc1.O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1nc(C(=O)O)c(CCCCOc3ccc(-n4ncc5cccnc54)cc3)s1)CC2
InChIInChI=1S/C37H31N7O4S2.C36H31N5O3S2.C32H30N4O3S2/c45-34(42-36-40-29-10-1-2-11-30(29)49-36)27-9-5-7-23-17-19-43(22-28(23)27)37-41-32(35(46)47)31(50-37)12-3-4-20-48-26-15-13-25(14-16-26)44-33-24(21-39-44)8-6-18-38-33;1-23(42)33-32(12-6-20-44-27-15-13-24(14-16-27)26-8-5-18-37-21-26)46-36(39-33)41-19-17-25-7-4-9-28(29(25)22-41)34(43)40-35-38-30-10-2-3-11-31(30)45-35;1-21(37)29-28(16-7-8-19-39-23-11-3-2-4-12-23)41-32(34-29)36-18-17-22-10-9-13-24(25(22)20-36)30(38)35-31-33-26-14-5-6-15-27(26)40-31/h1-2,5-11,13-16,18,21H,3-4,12,17,19-20,22H2,(H,46,47)(H,40,42,45);2-5,7-11,13-16,18,21H,6,12,17,19-20,22H2,1H3,(H,38,40,43);2-6,9-15H,7-8,16-20H2,1H3,(H,33,35,38)
InChIKeyNZNATYYBYRXCAR-UHFFFAOYSA-N
XLogP22.42
TPSA317.09 Ų
H-Bond Donors4
H-Bond Acceptors28
Rotatable Bonds31
Heavy Atoms137
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001930.39
LogP ≤ 522.42
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1028

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze 2-[4-acetyl-5-(4-phenoxybutyl)-1,3-thiazol-2-yl]-N-(1,3-benzothiazol-2-yl)-3,4-dihydro-1H-isoquinoline-8-carboxamide;2-[4-acetyl-5-[3-(4-pyridin-3-ylphenoxy)propyl]-1,3-thiazol-2-yl]-N-(1,3-benzothiazol-2-yl)-3,4-dihydro-1H-isoquinoline-8-carboxamide;2-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]-5-[4-(4-pyrazolo[5,4-b]pyridin-1-ylphenoxy)butyl]-1,3-thiazole-4-carboxylic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-[4-acetyl-5-(4-phenoxybutyl)-1,3-thiazol-2-yl]-N-(1,3-benzothiazol-2-yl)-3,4-dihydro-1H-isoquinoline-8-carboxamide;2-[4-acetyl-5-[3-(4-pyridin-3-ylphenoxy)propyl]-1,3-thiazol-2-yl]-N-(1,3-benzothiazol-2-yl)-3,4-dihydro-1H-isoquinoline-8-carboxamide;2-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]-5-[4-(4-pyrazolo[5,4-b]pyridin-1-ylphenoxy)butyl]-1,3-thiazole-4-carboxylic acid?
The IUPAC name of 2-[4-acetyl-5-(4-phenoxybutyl)-1,3-thiazol-2-yl]-N-(1,3-benzothiazol-2-yl)-3,4-dihydro-1H-isoquinoline-8-carboxamide;2-[4-acetyl-5-[3-(4-pyridin-3-ylphenoxy)propyl]-1,3-thiazol-2-yl]-N-(1,3-benzothiazol-2-yl)-3,4-dihydro-1H-isoquinoline-8-carboxamide;2-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]-5-[4-(4-pyrazolo[5,4-b]pyridin-1-ylphenoxy)butyl]-1,3-thiazole-4-carboxylic acid (CID 159929986) is 2-[4-acetyl-5-(4-phenoxybutyl)-1,3-thiazol-2-yl]-N-(1,3-benzothiazol-2-yl)-3,4-dihydro-1H-isoquinoline-8-carboxamide;2-[4-acetyl-5-[3-(4-pyridin-3-ylphenoxy)propyl]-1,3-thiazol-2-yl]-N-(1,3-benzothiazol-2-yl)-3,4-dihydro-1H-isoquinoline-8-carboxamide;2-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]-5-[4-(4-pyrazolo[5,4-b]pyridin-1-ylphenoxy)butyl]-1,3-thiazole-4-carboxylic acid.
What is the SMILES notation for 2-[4-acetyl-5-(4-phenoxybutyl)-1,3-thiazol-2-yl]-N-(1,3-benzothiazol-2-yl)-3,4-dihydro-1H-isoquinoline-8-carboxamide;2-[4-acetyl-5-[3-(4-pyridin-3-ylphenoxy)propyl]-1,3-thiazol-2-yl]-N-(1,3-benzothiazol-2-yl)-3,4-dihydro-1H-isoquinoline-8-carboxamide;2-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]-5-[4-(4-pyrazolo[5,4-b]pyridin-1-ylphenoxy)butyl]-1,3-thiazole-4-carboxylic acid?
The canonical SMILES for 2-[4-acetyl-5-(4-phenoxybutyl)-1,3-thiazol-2-yl]-N-(1,3-benzothiazol-2-yl)-3,4-dihydro-1H-isoquinoline-8-carboxamide;2-[4-acetyl-5-[3-(4-pyridin-3-ylphenoxy)propyl]-1,3-thiazol-2-yl]-N-(1,3-benzothiazol-2-yl)-3,4-dihydro-1H-isoquinoline-8-carboxamide;2-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]-5-[4-(4-pyrazolo[5,4-b]pyridin-1-ylphenoxy)butyl]-1,3-thiazole-4-carboxylic acid is CC(=O)c1nc(N2CCc3cccc(C(=O)Nc4nc5ccccc5s4)c3C2)sc1CCCCOc1ccccc1.CC(=O)c1nc(N2CCc3cccc(C(=O)Nc4nc5ccccc5s4)c3C2)sc1CCCOc1ccc(-c2cccnc2)cc1.O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1nc(C(=O)O)c(CCCCOc3ccc(-n4ncc5cccnc54)cc3)s1)CC2.
What is the InChIKey of 2-[4-acetyl-5-(4-phenoxybutyl)-1,3-thiazol-2-yl]-N-(1,3-benzothiazol-2-yl)-3,4-dihydro-1H-isoquinoline-8-carboxamide;2-[4-acetyl-5-[3-(4-pyridin-3-ylphenoxy)propyl]-1,3-thiazol-2-yl]-N-(1,3-benzothiazol-2-yl)-3,4-dihydro-1H-isoquinoline-8-carboxamide;2-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]-5-[4-(4-pyrazolo[5,4-b]pyridin-1-ylphenoxy)butyl]-1,3-thiazole-4-carboxylic acid?
The InChIKey is NZNATYYBYRXCAR-UHFFFAOYSA-N. The full InChI is InChI=1S/C37H31N7O4S2.C36H31N5O3S2.C32H30N4O3S2/c45-34(42-36-40-29-10-1-2-11-30(29)49-36)27-9-5-7-23-17-19-43(22-28(23)27)37-41-32(35(46)47)31(50-37)12-3-4-20-48-26-15-13-25(14-16-26)44-33-24(21-39-44)8-6-18-38-33;1-23(42)33-32(12-6-20-44-27-15-13-24(14-16-27)26-8-5-18-37-21-26)46-36(39-33)41-19-17-25-7-4-9-28(29(25)22-41)34(43)40-35-38-30-10-2-3-11-31(30)45-35;1-21(37)29-28(16-7-8-19-39-23-11-3-2-4-12-23)41-32(34-29)36-18-17-22-10-9-13-24(25(22)20-36)30(38)35-31-33-26-14-5-6-15-27(26)40-31/h1-2,5-11,13-16,18,21H,3-4,12,17,19-20,22H2,(H,46,47)(H,40,42,45);2-5,7-11,13-16,18,21H,6,12,17,19-20,22H2,1H3,(H,38,40,43);2-6,9-15H,7-8,16-20H2,1H3,(H,33,35,38).
What are the key properties of 2-[4-acetyl-5-(4-phenoxybutyl)-1,3-thiazol-2-yl]-N-(1,3-benzothiazol-2-yl)-3,4-dihydro-1H-isoquinoline-8-carboxamide;2-[4-acetyl-5-[3-(4-pyridin-3-ylphenoxy)propyl]-1,3-thiazol-2-yl]-N-(1,3-benzothiazol-2-yl)-3,4-dihydro-1H-isoquinoline-8-carboxamide;2-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]-5-[4-(4-pyrazolo[5,4-b]pyridin-1-ylphenoxy)butyl]-1,3-thiazole-4-carboxylic acid?
2-[4-acetyl-5-(4-phenoxybutyl)-1,3-thiazol-2-yl]-N-(1,3-benzothiazol-2-yl)-3,4-dihydro-1H-isoquinoline-8-carboxamide;2-[4-acetyl-5-[3-(4-pyridin-3-ylphenoxy)propyl]-1,3-thiazol-2-yl]-N-(1,3-benzothiazol-2-yl)-3,4-dihydro-1H-isoquinoline-8-carboxamide;2-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]-5-[4-(4-pyrazolo[5,4-b]pyridin-1-ylphenoxy)butyl]-1,3-thiazole-4-carboxylic acid has a molecular weight of 1930.39 g/mol, XLogP of 22.42, 31 rotatable bonds, 4 hydrogen bond donors, and 28 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[4-acetyl-5-(4-phenoxybutyl)-1,3-thiazol-2-yl]-N-(1,3-benzothiazol-2-yl)-3,4-dihydro-1H-isoquinoline-8-carboxamide;2-[4-acetyl-5-[3-(4-pyridin-3-ylphenoxy)propyl]-1,3-thiazol-2-yl]-N-(1,3-benzothiazol-2-yl)-3,4-dihydro-1H-isoquinoline-8-carboxamide;2-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]-5-[4-(4-pyrazolo[5,4-b]pyridin-1-ylphenoxy)butyl]-1,3-thiazole-4-carboxylic acid is sourced from PubChem (CID 159929986), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).